Back
First Trust S&P 500 Diversified Free Cash Flow ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Sell
42
FCFY
First Trust S&P 500 Diversified Free Cash Flow ETF
Last Price:
$28.04
Seasonality Move:
-0.17%
Sell
26
ORKA
Oruka Therapeutics, Inc.
Last Price:
$30.39
Seasonality Move:
-9.32%
Sell
42
First Trust S&P 500 Diversified Free Cash Flow ETF (FCFY)
is a Sell
Is First Trust S&P 500 Diversified Free Cash Flow ETF a Buy, Sell or Hold?
-
The current First Trust S&P 500 Diversified Free Cash Flow ETF [FCFY] share price is $27.66. The Score for FCFY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
FCFY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $30.31. The Score for ORKA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCFY Stock Price Chart
What is First Trust S&P 500 Diversified Free Cash Flow ETF's stock price today?
-
The First Trust S&P 500 Diversified Free Cash Flow ETF share price today is $27.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCFY is experiencing slight buying pressure.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $30.31The current trend is moderately bullish and ORKA is experiencing slight buying pressure.
FCFY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 52.78 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.02 - 28.08) | Buy |
| Bollinger Bands (100): | (26.18 - 27.48) | Buy |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 51.81 | Buy |
| Chaikin Money Flow: | 234570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29 - 31.58) | Buy |
| Bollinger Bands (100): | (16.97 - 29.87) | Buy |
FCFY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.91 | Sell |
| 20-day SMA: | 27.77 | Sell |
| 50-day SMA: | 27.05 | Buy |
| 200-day SMA: | 25.32 | Buy |
| 8-day EMA: | 27.86 | Sell |
| 20-day EMA: | 27.66 | Buy |
| 50-day EMA: | 27.21 | Buy |
| 200-day EMA: | 25.88 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.21 | Sell |
| 20-day SMA: | 30.53 | Sell |
| 50-day SMA: | 28.99 | Buy |
| 200-day SMA: | 17.48 | Buy |
| 8-day EMA: | 30.57 | Sell |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.26 | Buy |
| 200-day EMA: | 21.62 | Buy |
First Trust S&P 500 Diversified Free Cash Flow ETF Earnings Growth & FCFY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and a decrease next year of $0.42 per share.
First Trust S&P 500 Diversified Free Cash Flow ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||